AYTU BIOPHARMA, INC — Investor Relations & Filings
Filings indexed
890
across all filing types
Latest filing
2026-02-17
Major Shareholding Noti…
Country
US
United States of America
Listing
US
AYTU
Aytu BioPharma, Inc. is a specialty pharmaceutical company focused on developing and commercializing novel therapeutics. The company concentrates on advancing innovative medicines for complex central nervous system (CNS) diseases, with a particular emphasis on treatments for Attention-Deficit/Hyperactivity Disorder (ADHD) and Major Depressive Disorder (MDD). Its business model involves identifying, acquiring, and commercializing new products to improve the quality of life for patients with unmet medical needs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| SCHEDULE 13G/A Filing | 2026-02-17 | English | |
| SCHEDULE 13G/A Filing | 2026-02-13 | English | |
| 10-Q Filing | 2026-02-03 | English | |
| 8-K Filing | 2026-02-03 | English | |
| 8-K Filing | 2026-01-20 | English | |
| FORM 8-K | 2025-12-10 | English |
Browse filings by year
20 years- 2026 5 filings
- 2025 58 filings
- 2024 39 filings
- 2023 62 filings
- 2022 80 filings
- 2021 59 filings
- 2020 121 filings
- 2019 75 filings
- 2018 73 filings
- 2017 89 filings
- 2016 119 filings
- 2015 58 filings
- 2014 5 filings
- 2013 4 filings
- 2012 3 filings
- 2011 8 filings
- 2010 7 filings
- 2009 4 filings
- 2008 7 filings
- 2007 14 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
5 filings
| |||||
| 29286123 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 29286106 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 29286122 | 10-Q Filing | 2026-02-03 | English | ||
| 29286101 | 8-K Filing | 2026-02-03 | English | ||
| 29286128 | 8-K Filing | 2026-01-20 | English | ||
|
2025
10 filings
| |||||
| 12094658 | FORM 8-K | 2025-12-10 | English | ||
| 12094656 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 12094669 | FORM 10-Q | 2025-11-13 | English | ||
| 12094674 | FORM 8-K | 2025-11-13 | English | ||
| 12094676 | Major Shareholding Notification 2025 | 2025-11-12 | English | ||
| 12094678 | ARS | 2025-10-24 | English | ||
| 12094679 | FORM DEFA14A | 2025-10-24 | English | ||
| 12094680 | FORM DEF 14A | 2025-10-24 | English | ||
| 12094681 | Director's Dealing 2025 | 2025-10-20 | English | ||
| 12094682 | FORM 4 | 2025-10-07 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Ajanta Pharma Ltd.
Specialty pharmaceutical firm focused on complex generics a…
|
AJANTPHARM | IN | Manufacturing |
|
Akari Therapeutics Plc
Develops next-gen antibody-drug conjugates using proprietar…
|
AKTX | US | Manufacturing |
|
Akebia Therapeutics, Inc.
A biopharmaceutical company that develops and commercialize…
|
AKBA | US | Manufacturing |
|
Akeso, Inc.
Global commercial-stage biopharma developing innovative ant…
|
9926 | KY | Manufacturing |
|
Aktis Oncology, Inc.
A clinical-stage biotech developing targeted alpha radiopha…
|
AKTS | US | Manufacturing |
|
Akums Drugs and Pharmaceuticals Limited
CDMO providing end-to-end pharmaceutical manufacturing and …
|
AKUMS | IN | Manufacturing |
|
Albert David Ltd.
Produces pharmaceutical formulations, infusions, and specia…
|
ALBERTDAVD | IN | Manufacturing |
|
Aldeyra Therapeutics, Inc.
Develops medications for immune-mediated ocular and systemi…
|
ALDX | US | Manufacturing |
|
Aleafia Health Inc.
Vertically integrated cannabis company with cultivation, pr…
|
AH | CA | Manufacturing |
|
Alector, Inc.
Clinical-stage biotech using immuno-neurology to treat neur…
|
ALEC | US | Manufacturing |
AYTU BIOPHARMA, INC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35030/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35030 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35030 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35030 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35030}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for AYTU BIOPHARMA, INC (id: 35030)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.